Published in Lakartidningen on May 03, 2010
How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr (2002) 8.31
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology (2005) 5.92
Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol (2006) 3.82
Gene expression perturbation in vitro--a growing case for three-dimensional (3D) culture systems. Semin Cancer Biol (2005) 2.35
Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J Pediatr Gastroenterol Nutr (2010) 2.13
WW domains provide a platform for the assembly of multiprotein networks. Mol Cell Biol (2005) 1.97
[An announcement of concern about antibiotics in chicken feed]. Tidsskr Nor Laegeforen (2015) 1.96
Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proc Natl Acad Sci U S A (2005) 1.78
Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med (2011) 1.78
Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective. Semin Cell Dev Biol (2009) 1.78
Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila. Front Microbiol (2011) 1.69
High frequency somatic mutations in RASSF1A in nasopharyngeal carcinoma. Cancer Biol Ther (2005) 1.53
Scintigraphy of the small intestine: a simplified standard for study of transit with reference to normal values. Eur J Nucl Med Mol Imaging (2001) 1.50
Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer (2004) 1.49
Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors. Comp Med (2010) 1.47
Determinants of the human infant intestinal microbiota after the introduction of first complementary foods in infant samples from five European centres. Microbiology (2011) 1.44
Effects of a supplementary diet with specially processed cereals in patients with short bowel syndrome. Eur J Gastroenterol Hepatol (2008) 1.41
RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies. Proc Natl Acad Sci U S A (2004) 1.39
[The history of antibiotics]. Tidsskr Nor Laegeforen (2013) 1.38
Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. J Virol (2005) 1.30
Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells. Am J Pathol (2008) 1.29
Stability, persistence, and evolution of plasmid-encoded VanA glycopeptide resistance in enterococci in the absence of antibiotic selection in vitro and in gnotobiotic mice. Microb Drug Resist (2002) 1.27
Eight-signature classifier for prediction of nasopharyngeal [corrected] carcinoma survival. J Clin Oncol (2011) 1.23
Development of gut microbiota in infants not exposed to medical interventions. APMIS (2010) 1.23
Comparison of enterococcal populations in animals, humans, and the environment--a European study. Int J Food Microbiol (2003) 1.23
Quantifying the species-specificity in genomic signatures, synonymous codon choice, amino acid usage and G+C content. Gene (2003) 1.22
Fecal transplant against relapsing Clostridium difficile-associated diarrhea in 32 patients. Scand J Gastroenterol (2012) 1.21
Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma. Anticancer Res (2005) 1.20
The molecular portrait of in vitro growth by meta-analysis of gene-expression profiles. Genome Biol (2005) 1.17
High prevalence of vancomycin-resistant enterococci in Swedish sewage. Appl Environ Microbiol (2002) 1.14
Evaluation of redox indicators and the use of digital scanners and spectrophotometer for quantification of microbial growth in microplates. J Microbiol Methods (2002) 1.13
Identification and characterization of pathogenic Aeromonas veronii biovar sobria associated with epizootic ulcerative syndrome in fish in Bangladesh. Appl Environ Microbiol (2002) 1.12
Prevalence of diarrhoeagenic Escherichia coli in children from León, Nicaragua. J Med Microbiol (2009) 1.11
NotI subtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes. Proc Natl Acad Sci U S A (2002) 1.10
Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. PLoS One (2011) 1.09
Antimicrobial resistance in urinary bacterial isolates from pregnant women in rural Tanzania: implications for public health. Scand J Infect Dis (2005) 1.08
Antibiotic or bacterial therapy in post-giardiasis irritable bowel syndrome. Scand J Gastroenterol (2009) 1.08
[There is not enough research being done!]. Tidsskr Nor Laegeforen (2013) 1.06
A new approach to genome mapping and sequencing: slalom libraries. Nucleic Acids Res (2002) 1.05
High frequency loss of heterozygosity on the long arms of chromosomes 13 and 14 in nasopharyngeal carcinoma in Southern China. Chin Med J (Engl) (2002) 1.05
Occurrence and relatedness of vancomycin-resistant enterococci in animals, humans, and the environment in different European regions. Appl Environ Microbiol (2005) 1.04
Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker. Oral Oncol (2006) 1.04
Carbohydrate intolerance in patients with self-reported food hypersensitivity: comparison of lactulose and glucose. Scand J Gastroenterol (2009) 1.03
Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays. Epigenetics (2012) 1.03
Epidemiological link between wastewater and human vancomycin-resistant Enterococcus faecium isolates. Curr Microbiol (2008) 1.01
Alignment-independent comparisons of human gastrointestinal tract microbial communities in a multidimensional 16S rRNA gene evolutionary space. Appl Environ Microbiol (2007) 1.00
Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study. Inflamm Bowel Dis (2011) 1.00
Novel developmental analyses identify longitudinal patterns of early gut microbiota that affect infant growth. PLoS Comput Biol (2013) 0.99
Increase of faecal tryptic activity relates to changes in the intestinal microbiome: analysis of Crohn's disease with a multidisciplinary platform. PLoS One (2013) 0.99
Microbial colonization drives lymphocyte accumulation and differentiation in the follicle-associated epithelium of Peyer's patches. J Immunol (2003) 0.98
Asymptomatic norovirus infections in Nicaraguan children and its association with viral properties and histo-blood group antigens. Pediatr Infect Dis J (2010) 0.96
CDH4 as a novel putative tumor suppressor gene epigenetically silenced by promoter hypermethylation in nasopharyngeal carcinoma. Cancer Lett (2011) 0.96
The Staphylococcus aureus alpha-toxin perturbs the barrier function in Caco-2 epithelial cell monolayers by altering junctional integrity. Infect Immun (2012) 0.96
Expression of Clostridium difficile toxins A and B and their sigma factor TcdD is controlled by temperature. Infect Immun (2003) 0.96
Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population. Clin Vaccine Immunol (2010) 0.95
Evidence for transmission between humans and the environment of a nosocomial strain of Enterococcus faecium. Environ Microbiol (2004) 0.95
Manipulation of the gut microbiota in C57BL/6 mice changes glucose tolerance without affecting weight development and gut mucosal immunity. Res Vet Sci (2011) 0.94
Probiotics and clinical effects: is the number what counts? J Chemother (2013) 0.94
Transfer of plasmid and chromosomal glycopeptide resistance determinants occurs more readily in the digestive tract of mice than in vitro and exconjugants can persist stably in vivo in the absence of glycopeptide selection. J Antimicrob Chemother (2007) 0.94
An anthroposophic lifestyle and intestinal microflora in infancy. Pediatr Allergy Immunol (2002) 0.93
The Escherichia coli BarA-UvrY two-component system is a virulence determinant in the urinary tract. BMC Microbiol (2006) 0.93
Antibiotic resistance patterns of intestinal Escherichia coli isolates from Nicaraguan children. J Med Microbiol (2010) 0.92
Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1. Virus Genes (2008) 0.92
Evaluation of a scanner-assisted colorimetric MIC method for susceptibility testing of gram-negative fermentative bacteria. Appl Environ Microbiol (2004) 0.92
High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer. PLoS One (2009) 0.91
Abrogated lymphocyte infiltration and lowered CD14 in dextran sulfate induced colitis in mice treated with p65 antisense oligonucleotides. Int J Colorectal Dis (2002) 0.91
Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease. Scand J Gastroenterol (2012) 0.91
Generation of NO by probiotic bacteria in the gastrointestinal tract. Free Radic Biol Med (2006) 0.91
Immune response to Mycoplasma pulmonis in nasal mucosa is modulated by the normal microbiota. Am J Respir Cell Mol Biol (2004) 0.91
DNA-dependent conversion of Oct-1 and Oct-2 into transcriptional repressors by Groucho/TLE. Nucleic Acids Res (2005) 0.89
Microbial colonization induces oligoclonal expansions of intraepithelial CD8 T cells in the gut. Eur J Immunol (2004) 0.89
Faecal short-chain fatty acid pattern in childhood coeliac disease is normalised after more than one year's gluten-free diet. Microb Ecol Health Dis (2013) 0.88
A genome-wide scan suggests a susceptibility locus on 5p 13 for nasopharyngeal carcinoma. Eur J Hum Genet (2008) 0.88
Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population. BMC Cancer (2006) 0.88
Clonal heterogeneity of clinical isolates of vancomycin-resistant Enterococcus faecium with unique vanS. Trop Med Int Health (2008) 0.88
Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life. Scand J Gastroenterol (2013) 0.87
Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma. Anticancer Res (2004) 0.87
The PhenePlate system for studies of the diversity of enterococcal populations from the food chain and the environment. Int J Food Microbiol (2003) 0.87
Persistence, transmission, and virulence characteristics of Aeromonas strains in a duckweed aquaculture-based hospital sewage water recycling plant in Bangladesh. Appl Environ Microbiol (2006) 0.86
Epstein-Barr virus latent membrane 2A (LMP2A) down-regulates telomerase reverse transcriptase (hTERT) in epithelial cell lines. Int J Cancer (2005) 0.86
The Epstein-Barr virus protein, latent membrane protein 2A, co-opts tyrosine kinases used by the T cell receptor. J Biol Chem (2005) 0.86
Response to Surawicz et al. Am J Gastroenterol (2013) 0.85
The K15 protein of Kaposi's sarcoma-associated herpesvirus recruits the endocytic regulator intersectin 2 through a selective SH3 domain interaction. Biochemistry (2007) 0.85
Three-dimensional culturing of the Hodgkin lymphoma cell-line L1236 induces a HL tissue-like gene expression pattern. Leuk Lymphoma (2007) 0.85
Lack of detectable DNA uptake by bacterial gut isolates grown in vitro and by Acinetobacter baylyi colonizing rodents in vivo. Environ Biosafety Res (2007) 0.84
Development of a non-invasive method, multiplex methylation specific PCR (MMSP), for early diagnosis of nasopharyngeal carcinoma. PLoS One (2012) 0.83
The Effect of Antiretroviral Combination Treatment on Epstein-Barr Virus (EBV) Genome Load in HIV-Infected Patients. Viruses (2010) 0.83
Epstein-Barr virus-encoded LMP1 promotes cisplatin-induced caspase activation through JNK and NF-kappaB signaling pathways. Biochem Biophys Res Commun (2007) 0.83
Faecal short chain fatty acid pattern and allergy in early childhood. Acta Paediatr (2009) 0.83
The role of c-di-GMP signaling in an Aeromonas veronii biovar sobria strain. FEMS Microbiol Lett (2007) 0.83